<DOC>
	<DOC>NCT01632813</DOC>
	<brief_summary>The key objective of the Leuven growing-into-deficit (GID) follow-up-study is to test the hypothesis that children with a congenital heart disease (CHD) show more neurocognitive impairment at the second follow-up at 7 years old than at the first follow-up at the age of 4, compared to healthy controls.</brief_summary>
	<brief_title>Leuven Growing Into Deficit Follow-up Study</brief_title>
	<detailed_description />
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Congenital Abnormalities</mesh_term>
	<mesh_term>Heart Defects, Congenital</mesh_term>
	<criteria>Sevenyearold children with CHD and healthy control children who were four years old when they participated in Paediatric ICU followup study (i.e. first followup time point) (Neurocognitive development of children four years after critical illness and treatment with tight glucose control, Clinical Trials # NCT00214916). The children of the CHDgroup underwent cardiac surgery as infants (=&lt;1year). Genetic syndromes (Down, 22q11del), known to result in neurocognitive impairment IQ &lt; 70 Lack of baseline neurocognitive measurements during first followup Date of birth before February 2005</criteria>
	<gender>All</gender>
	<minimum_age>84 Months</minimum_age>
	<maximum_age>89 Months</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>neurocognitive testing</keyword>
	<keyword>critical illness</keyword>
	<keyword>executive function</keyword>
	<keyword>intelligence</keyword>
</DOC>